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A B S T R A C T
Local field potentials (LFPs) may afford insight into the mechanisms of action of deep brain stimulation (DBS)
and potential feedback signals for adaptive DBS. In Parkinson's disease (PD) DBS of the subthalamic nucleus
(STN) suppresses spontaneous activity in the beta band and drives evoked resonant neural activity (ERNA). Here,
we investigate how STN LFP activities change over time following the onset and offset of DBS. To this end we
recorded LFPs from the STN in 14 PD patients during long (mean: 181.2 s) and short (14.2 s) blocks of con-
tinuous stimulation at 130 Hz. LFP activities were evaluated in the temporal and spectral domains. During long
stimulation blocks, the frequency and amplitude of the ERNA decreased before reaching a steady state after
~70 s. Maximal ERNA amplitudes diminished over repeated stimulation blocks. Upon DBS cessation, the ERNA
was revealed as an under-damped oscillation, and was more marked and lasted longer after short duration
stimulation blocks. In contrast, activity in the beta band suppressed within 0.5 s of continuous DBS onset and
drifted less over time. Spontaneous activity was also suppressed in the low gamma band, suggesting that the
effects of high frequency stimulation on spontaneous oscillations may not be selective for pathological beta
activity. High frequency oscillations were present in only six STN recordings before stimulation onset and their
frequency was depressed by stimulation. The different dynamics of the ERNA and beta activity with stimulation
imply different DBS mechanisms and may impact how these activities may be used in adaptive feedback.
1. Introduction
Deep brain stimulation (DBS) has proven a successful treatment for
advanced Parkinson's Disease (PD) since it was pioneered by Alim-Louis
Benabid in 1987 (Lozano et al., 2019; Okun, 2012). Since then the
paradigm has remained relatively unchanged and comprises continuous
high-frequency stimulation delivered at a fixed frequency (usually
130 Hz) to either the subthalamic nucleus (STN) or the internal globus
pallidus (GPi). Despite its success, the mechanisms of action of DBS
remain largely unexplained (Muthuraman et al., 2018). This is im-
portant as DBS can elicit stimulation-related side effects that include
speech impairment, neuropsychiatric symptoms and paradoxical wor-
sening of motor functions (Chen et al., 2006a; Okun, 2012; Parsons
et al., 2006). An understanding of the mechanisms of action of DBS
could enable development of DBS strategies that are more specific,
causing fewer side-effects, and even more effective, should it prove
possible to directly counter the key malfunctions in neural circuits. In
particular, there has been much recent interest in the possibility of
controlling DBS using feedback from electrophysiological signals
(Bouthour et al., 2019; Little and Brown, 2020; Lozano et al., 2019).
In order to clarify the mechanisms of action of DBS and seek suitable
feedback signals it makes sense to examine the effects of DBS on neural
circuits at the point of stimulation. Thus far two major direct con-
sequences of stimulation have been identified in the STN; the sup-
pression of beta-band activity in the local field potential (LFP) and the
stimulation evoked resonant neural activity (ERNA; Sinclair et al.,
2018). The former has been suggested as a potential mechanism un-
derlying effective DBS, based on the growing evidence that Parkinson's
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disease is associated with exaggerated synchronisation of basal ganglia
neurons in the beta frequency band (13–35 Hz; Brown, 2003; Eusebio
et al., 2011; Kühn et al., 2008; Quinn et al., 2015). The ERNA has been
more recently reported, and can be described as a robust, decaying,
large-amplitude and high-frequency oscillation following DBS pulses
(Sinclair et al., 2018, 2019b). It has been confirmed to be of neural
origin and is modulated by changes in DBS parameters, although its
relationship to DBS mechanisms has barely been explored (Sinclair
et al., 2019a).
The ERNA and beta activity are quite different, not least in their
amplitudes, and yet both have been suggested as possible feedback
signals to be used in adaptive DBS given evidence that they may cor-
relate with motor impairment (Kühn et al., 2006; Kühn et al., 2009;
Little et al., 2013; Sinclair et al., 2018). Here, we aim to investigate the
responses of these two activities to high-frequency stimulation of the
STN with special reference to the temporal dynamics of their responses.
Our findings suggest that the different responses of the two activities
may provide a window into different mechanisms underlying the effects
of DBS of the STN whilst also constraining their use as feedback para-
meters in adaptive DBS.
2. Materials and methods
2.1. Patients and surgery
Fourteen patients with PD (two females) undergoing bilateral STN-
DBS surgery participated in the study. Their mean age at the time of the
recording was 58 ± 1.7 years (mean ± SEM) with average disease
duration of 11.2 ± 1.1 years. Patients were recruited at St. George's
University Hospital NHS Foundation Trust, London (UK) and at the
University Medical Center of the Johannes Gutenberg University, Mainz
(DE) and they all gave their written informed consent to participate in
the experiment approved by the local ethics committees (St. George's
University Hospital, IRAS: 46576; Mainz University Hospital:
837.208.17(11042)). The clinical details of the patients are reported in
Table 1 along with details of the surgical interventions and recordings
(Table 2). UPDRS Part III scores were determined pre-operatively.
The implanted leads were the Medtronic 3389 (Medtronic Inc.,
Neurological Division, USA) with four 0.5 mm spaced contacts of
1.5 mm length with platinum‑iridium cylindrical surfaces, or the di-
rectional leads from Boston Scientific (model DB-2202, Boston
Scientific, USA) or St. Jude Medical (model 6170, St. Jude Medical, now
Abbott, USA), both having three segmented contacts on the middle
levels. DBS implantation was guided either by magnetic resonance
imaging alone (St. George's University Hospital) or with additional
intra-operative micro-recordings and intra-operative stimulation
(University Medical Center, Mainz).
2.2. Stimulation and data recording
Recordings were made between 2 and 5 days postoperatively
(Table 2), while electrode leads were still externalised and before im-
plantation of the subcutaneous pulse generator. All patients performed
the experiments after overnight withdrawal of antiparkinsonian medi-
cation. For the patients implanted with directional leads, the directional
contacts of levels 1 and 2 were joined together to form one ‘ring con-
tact’ so that each lead afforded four monopolar ring contacts. The four
contacts were then numbered from E0 to E3 with contact 0 being the
most ventral and contact 3 being the most dorsal (see Fig. 1A). Sti-
mulation was only tested at the two middle contacts (E1 and E2) to
allow bipolar LFP recordings from the two adjacent contacts (see end of
this paragraph and Fig. 1A). A self-adhesive electrode (Pals, Nidd Valley
Medical, Bordon, UK) attached to the back of the participants' shoulders
served as reference for the stimulation, which was delivered using a
highly configurable neurostimulator (Slater et al., 2015). Stimuli
comprised symmetric constant-current biphasic pulses (60 μs per phase,
negative phase first). For each of the two contacts, stimulation was
started at 0.5 mA and slowly increased by 0.5 mA increments every 3 to
4 min until a clear clinical benefit in rigidity and/or bradykinesia was
observed or side effects such as paresthesia became apparent. The sti-
mulation contact and current associated with the most clinically ef-
fective stimulation without side effects was then selected and main-
tained for the entire experiment (Table 2). This procedure was
performed on the side contralateral to the most affected upper limb in
12 subjects and bilaterally in 2 subjects. A stimulation frequency of
130 Hz was used throughout.
Signals were amplified and sampled at 2048 Hz using a TMSi Porti
and its respective software (TMS International, Netherlands). STN LFPs
were recorded bipolarly from the two contacts either side of the contact
used for stimulation, for common reference removal (Schiff, 2005). The
ground electrode was placed on the forearm.
2.3. Lead localisation determination
Assessment of contact localisation was made through co-registration
of immediate post-operative CT with pre-operative MRI by an experi-
enced neurosurgeon (E.A.P) or neurologist (S.G.) specialising in deep
brain stimulation. Assessment was blinded to the electrophysiological
data and made using Renishaw Neuroinspire v6 software in London and
Lead-DBS (v2.0, Horn et al., 2019) in Mainz. These assessments are
summarised in Table 2.
2.4. Experimental protocol
During the experiment, patients were seated comfortably in an
armchair. The experimental protocol is summarised in Fig. 1B and
consisted of two conditions preceded by 2 min of rest recordings
without stimulation (baseline). In the first condition, continuous
130 Hz DBS was applied for 181.2 ± 7.3 s (mean ± SEM) in up to
four consecutive blocks separated by resting periods of on average
Table 1
Patients clinical details. Pre-op: Preoperative. UPDRS-III: Part III motor score of
the Unified Parkinson's Disease Rating Scale. The last three cases had no evi-
dence of an ERNA (see Table 2).
Sub. Gender
(m/f)
Age
(yr)
Disease
Duration
(yr)
Pre-OP
UPDRS-III
OFF
Pre-OP
UPDRS-III
ON
Pre-dominant
symptoms
1 m 61 16 50 30 Gait freezing,
motor fluctuations
2 m 48 17 71 37 Rigidity, tremor,
gait freezing
3 m 54 7 38 24 Tremor
4 m 56 16 51 19 Rigidity,
bradykinesia
5 m 65 5 34 16 Gait freezing,
motor fluctuations
6 m 51 5 27 13 Bradykinesia,
rigidity,
motor fluctuations
7 f 63 11 40 17 Gait freezing,
motor fluctuations
8 m 64 13 52 21 Gait freezing,
motor fluctuations
9 m 61 10 31 19 Akinetic-rigid,
tremor
10 m 61 11 16 7 Akinetic-rigid
with fluctuations
11 m 53 7 23 12 Tremor
12 m 61 9 33 12 Right arm tremor,
bradykinesia
13 m 48 8 45 34 Tremor,
bradykinesia
14 f 67 13 18 15 Akinetic-rigid,
tremor
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117.1 ± 10.8 s. These are termed long duration stimulation blocks. In
the second condition, stimulation blocks were shortened to on average
14.2 ± 2.3 s with rest periods of 105.1 ± 16 s. This second condition
was performed to study how the ERNA's characteristics are modulated
by the duration of the preceding stimulation and both conditions were
separated by a resting period. In addition, the long duration stimulation
condition was long enough for clinical benefit to develop (Levin et al.,
2009; Lopiano et al., 2003). The rest period duration did not differ
between the two conditions (t(18) = 0.55, p = .59). Note that due to
patient fatigue and time constraints only a subset of patients performed
the short duration condition (n = 7 STN from 5 patients).
2.4.1. Terminology
The ERNA has previously only been described in the temporal do-
main, with the same term being used to describe evoked responses
during and at the termination of stimulation (Sinclair et al., 2018,
2019b). Here we also use the term ERNA to describe a feature in time-
frequency plots that upon steady-state has a similar frequency to the
repeating waves of the ERNA on cessation of stimulation. Time and
spectral domain representations also shared similar dynamics following
the onset of stimulation. Hence we use the term ERNA to denote all
three phenomena; the high frequency evoked response in time series
during stimulation, the high frequency response in time series evoked
by the last stimulus in a block of stimulation and the high frequency
spectral response during stimulation.
2.5. Signal processing: DBS evoked response
Signal processing was performed using custom-written scripts in
MATLAB (version 2019a, Mathworks, Massachusetts, USA).
2.6. ERNA during stimulation
Here, we determine ERNA characteristics in the frequency domain,
based on the premise that the ERNA is not sufficiently tuned as to be
wholly obscured by the stimulation artefact in frequency spectra. These
analyses were performed only during long stimulation blocks (condi-
tion 1). Continuous LFP signals were de-trended and stimulation arte-
facts were removed by applying second-order IIR notch filters (Q fac-
tors = 30) at the stimulation frequency and its harmonics. Spectral
amplitudes were estimated between 1 and 512 Hz using the short-time
Fourier transform with a window length of 1 s, 25% of overlap and a
Hamming window as implemented in MATLAB's spectrogram function
(see Fig. 1C for data from one STN). Each long stimulation block
(condition 1) was then divided into consecutive non-overlapping 10-s
epochs, in which power spectral densities (PSD) were estimated and
smoothed using a Gaussian kernel with 50 sampling points full-width.
The largest peak of the PSD between 200 and 400 Hz was used to define
the ERNA frequency and amplitude in each 10-s epoch (see Fig 2Aii and
Supplementary video V1). Based on the changes observed along the
consecutive 10-s epochs we then separately defined for each long
duration stimulation block two steady states corresponding to the sta-
bilisation of the ERNA frequency (Fig 2Aiii) and amplitude (Fig 2Aiv),
respectively. The onset of the steady state was defined based on the
derivative of the time profiles and corresponded to the centre of the first
epoch at which the derivative was encompassed in a band of± 5 Hz/s
(or μV/s for amplitude) centred around zero. This method allowed a
robust and objective threshold estimation while limiting the number of
arbitrary selected parameters.
The spectral analysis of the ERNA during continuous stimulation
was supported by its analysis in the time domain. To this end, the peaks
of the stimulation artefacts were identified and removed from the de-
Table 2
Patients surgical and recordings details. Medt: Medtronic. L: Lef., R: Right. STN(SP): Superior posterior part of sub-thalamic nucleus. MBSTN(SP): Medial border of
the superior posterior part of the sub-thalamic nucleus. Post lat to STN (SP): Posterio-lateral to the superior posterior part of the sub-thalamic nucleus. D: ERNA
during stimulation, A: ERNA after stimulation. Incl: STN included in the power analysis of local field potentials (LFP, beta and low gamma power). Mvt art: STN
excluded from LFP power analysis because of movement artefacts. Beta red: beta reduced. * only two blocks of which were consecutive (patients excluded from linear
mixed-effects models).
Sub. DBS
lead
Site Time
Recording
(d)
STN
tested
Location
Stim.
Contact
Stim.
Amp.
(mA)
Cond. no. of blocks
in cond. 1
ERNA LFP
Power
analysis
1 Boston St. George's
London
3 L STN (SP) 2 1,2 4 D,A Incl.
2 Boston St. George's
London
4 R STN (SP) 2 1 4 D Mvt art.
3 Boston St. George's
London
5 R STN (SP) 3,5 1 4 D,A Incl.
4 Medt St. George's
London
4 L STN (SP) 4 1 4 D,A Incl.
5 Boston St. George's
London
4 and 5 L MBSTN (SP) 3 1,2 3 D,A Incl.
4 R MBSTN (SP) 2,5 1,2 3 D,A Incl.
6 Boston St. George's
London
4 R MBSTN (SP) 4 1 4 D Mvt art.
7 Boston St. George's
London
4 L STN (SP) 2 1,2 3* D,A Incl.
8 Boston St. George's
London
4 R STN (SP) 2 1,2 3* D,A Incl.
9 Medt University Medical
Center, Mainz
3 L STN (SP) 4 1 4 D,A Incl.
10 St. Jude University Medical
Center, Mainz
2 R STN (SP) 3,5 1 4 D,A Incl.
11 Boston St. George's
London
4 R STN (SP) 2 1,2 4 D,A Incl.
5 L STN (SP) 3 1,2 4 D,A Incl.
12 Boston St. George's
London
4 L MBSTN (SP) 4 1 4 none Beta red.
13 Boston St. George's
London
5 L MBSTN (SP) 3 1 4 none No beta
change
14 Medt University Medical
Center, Mainz
3 L Post lat to
STN(SP)
1,5 1 4 none Beta red.
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trended LFP signals (removing 1.5 ms after each artefact to avoid any
contamination of the inter-trial interval by residual stimulus artefact).
Note that 1.5 ms was selected as sufficient to remove stimulus artefact
based on visual inspection. Then, the first ERNA peak was identified in
the inter-artefact intervals (~ 7.7 ms long) of the stimulation block as
the highest peak within the interval, and tracked throughout all con-
secutive intervals to measure its amplitude and latency (time between
artefact peak and first peak of the ERNA).
2.7. ERNA after stimulation
After cessation of stimulation the ERNA was assessed over a longer
time window which exposed its extended morphology characterised by
a series of 2–8 regularly spaced, but diminishing waves (Sinclair et al.,
2018, 2019b). The ERNA after stimulation was analysed as follows.
First, data were high-pass filtered at 80 Hz with a two-pass Butterworth
IIR filter (Oostenveld et al., 2011) and 50 ms data epochs were aligned
to the last reproducible stimulus artefact in a given block of stimulation.
ERNA duration was defined as the time between the last artefact peak
and the last detected ERNA peak within the 50-millisecond epoch.
Thereafter, the first 1.5 ms of each epoch was deleted to avoid further
contamination by residual stimulus artefact (see Fig. 4A). Second, peaks
and troughs in the ERNA response were found using the MATLAB
findpeaks function, with the following criteria;
MinPeakWidth = 0.5 ms, MinPeakProminence = 10 μV (Sinclair et al.,
2019b). ERNA responses were not further analysed, and considered
absent, if there were fewer than two peaks and two troughs. Finally,
ERNA initial frequency was calculated as the inverse of the time dif-
ference between the first and second peak and the initial amplitude was
calculated as the difference between the first peak and the subsequent
trough (Sinclair et al., 2019b). To evaluate the ERNA frequency change
after cessation of the stimulation, its frequency was also calculated as
the inverse of the time between the subsequent peaks.
2.8. Signal processing: spontaneous neural activity
2.8.1. Lower frequency band (1–95 Hz)
LFP signals were band-pass filtered between 1 and 95 Hz and
spectra were estimated using the short-time Fourier transform with a
higher temporal resolution than for the previous analysis (window
length of 125 ms, 50% of overlap) and a Hamming window filter. All
spectral power changes were defined in relation to a 10-s baseline
epoch recorded prior to the first stimulation block of every subject
which was free from any motion artefact. The modulation of resting,
spontaneous beta (13–34 Hz) and low gamma (35–45 Hz) power by
DBS was studied in two 30-s windows aligned to the first and last ar-
tefact in long duration stimulation blocks (from −10 to +20 s where
zero seconds is the onset and offset of stimulation, respectively). For
Fig. 1. Stimulation settings and experimental conditions. A. Schematic of the electrode configuration. Stimulation was applied to one of the two middle electrode
contacts (E1 or E2) and the LFPs recorded bipolarly from the two adjacent contacts (e.g.: E1-E3). B. Experimental protocol. The first condition started with a 2-min
baseline recording followed by continuous stimulation at 130 Hz in blocks of 181.2 ± 7.3 (mean ± SEM) seconds interleaved by about 117.1 ± 0.8 s of rest. In the
second condition, stimulation was shortened to 14.2 ± 2.3 s and separated by about 105.1 ± 16 s. Rest period duration did not differ between the two conditions
(t(18) = 0.55, p = .59) C. Spectral features over time in the two experimental conditions for patient 5. During stimulation, an ERNA appears between 300 Hz and
350 Hz (label 1) and its power attenuates while dropping in frequency until it reaches a steady state centred around 260 Hz (label 2). Stimulation blocks are denoted
by the grey rectangles at the top of the trace. In addition, during stimulation there is a prompt suppression of beta and low gamma power (label 3) and a modulation
of the HFO frequency (label 4) present before stimulation. Note that line noise artefacts are visible throughout the recordings at 50 Hz and its harmonics, along with
the stimulation artefact at 130 Hz and its harmonics, despite being reduced by notch filters. Movement artefacts, affecting mostly lower frequencies, are particularly
visible in the third stimulation block.
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both frequency bands, the time of power recurrence was defined after
the cessation of stimulation as an increase in power that reached or
surpassed the 95% confidence limits of baseline activity for at least
250 ms. For clinical correlations baseline beta power was normalised to
the percentage of total power of 5 to 45 Hz.
2.8.2. High Frequency Oscillations (HFO, 200-400 Hz)
Spontaneous activity in the high frequency range (200–400 Hz) was
studied in the absence of stimulation, as it can overlap with the fre-
quency range of the evolving ERNA. Power spectral densities were es-
timated using MATLAB's spectrogram function (same parameters as for
the ERNA during DBS) in 20-s windows during the baseline and at the
start or end of the resting periods (see Fig. 7A). In each window, the
HFO frequency peak was defined as the largest peak between 200 and
400 Hz.
2.9. Statistics
The statistical analyses were conducted using custom-written scripts
in MATLAB (MathWorks). Normality of the data was controlled before
any statistical test (Lilliefors test) and nonparametric statistics were
applied when necessary (as reported in Results). Comparison of group
data (ERNA characteristics and averaged power changes) across sti-
mulation blocks were performed with linear mixed-effects models and
the normal distribution of each variable was visually inspected with
quantile-quantile plots and histograms of distribution. All models were
estimated by the method of maximum likelihood and included random
intercept for subjects, to allow different intercepts for each subject
capturing individual differences. The time courses of power changes
were tested against zero with one-sample t-tests in sliding windows of
50 ms with a time shift between successive windows of 12.5 ms. The
False Discovery Rate was computed using the Benjamini-Hochberg
procedure (Benjamini and Hochberg, 1995) to correct for multiple
comparisons along the time axis. Since power data are not normally
distributed and contain outliers, we computed the Spearman correla-
tion between suppression of activity in the beta band, time to reach
ERNA steady state and symptom severity.
3. Results
3.1. ERNA during stimulation
We began by inspecting time-frequency plots of STN activity during
stimulation. A typical example from a representative patient is illu-
strated in Fig. 1C and shows, in the spectral domain, an activity sliding
down in frequency over time before overlapping with the narrower
band artefact at 260 Hz related to the first harmonic of the stimulation.
This pattern was observed in 13/16 tested STNs. Here we term this
activity ERNA based on its similarities to the ERNA previously de-
scribed in the time-domain (see Fig. 3 and Sinclair et al., 2019b, 2018).
Note that the absence of ERNA in three STNs is unlikely to be due to a
weaker stimulation amplitude (see Table 2 and Fig. S1). Rather it may
be related to targeting in so far as their stimulating contacts were lo-
calized to the medial border of the superior part of the STN or lay
outside and posterio-lateral to this part of the STN (see Table 2).
In order to study the frequency dynamics of the ERNA in more detail
we divided each stimulation block into consecutive 10-s windows and
plotted the peak frequency observed between 200 and 400 Hz over time
(see Fig. 2A and Supplementary video V1). We then extracted three
parameters for each stimulation block: the initial and steady state fre-
quencies, and the time at which the steady state was reached (see
Methods). We first asked whether the three parameters were consistent
over time, i.e. across stimulation blocks. To this end we only considered
those patients with at least three consecutive long duration stimulation
blocks (n = 11 STNs, including seven with four blocks). The results of
linear mixed-effects modelling revealed that both the initial and steady
state frequencies were stable over long duration stimulation blocks
(b = −0.45, t (38) = −0.37, p = .72 and b = 0.49, t (38) = 1.27,
p = .21, respectively, Fig. 2B). Moreover, the delay to reach the steady
state was also similar in consecutive blocks (b = −2.48, t
(38) = −1.86, p = .07). Thus, on average across all STNs and stimu-
lation blocks, the ERNA started at a frequency of 352.4 ± 4.9 Hz
(mean ± SEM) at the onset of stimulation and progressively decreased
in frequency over time to stabilise after 71.4 ± 2.6 s at a frequency of
263.2 ± 2.1 Hz.
In addition to the dynamics in frequency, we also explored the
dynamics in the ERNA amplitude, following the same procedure. As
shown in Fig. 2Aiv and 2C, the results revealed a different pattern. The
amplitude of the evoked response first briefly increased and then de-
creased to stabilize around a steady state at the end of the stimulation
block (after on average 81.7 ± 6.2 s). For each STN and each stimu-
lation block, we extracted five parameters describing this amplitude
dynamic; the initial, maximal and steady state amplitude, and the times
at which the maximal and steady state amplitudes were reached. The
linear mixed-effects modelling revealed a significant reduction of the
maximal amplitude and a shortening of the delay to reach the steady
state in consecutive blocks (b = −0.06, t (38) = −3.56, p = .013 and
b = −6.27, t (38) = −2.21, p = .03, respectively). The results are
confirmed when only the STNs with four consecutive blocks were in-
cluded in the model (maximal amplitude: b = −0.06, t (26) = −2.68,
p = .013 and steady state: b = −7.1, t (26) = −2.1, p = .047). This
control was performed to confirm that the previously reported statis-
tical effects were not related to the unbalanced design and the absence
of block 4 in some of the STNs. This modulation can be easily seen in
Fig. 2C bottom right where the amplitude time course of the first and
last stimulation block are overlaid. The three remaining parameters
were however stable in consecutive blocks; the time at which the
maximal amplitude was reached (b = 0.21, t (38) = 0.07, p = .94) as
well as the initial and steady state amplitudes (b = −0.004, t
(38) = −0.26, p = .8 and b = 0.01, t (38) = 1, p = .32, respectively).
Finally, the frequency and amplitude steady states were reached after a
similar delay (paired t-tests, t(12) = −1.01, p = .3 for the first block,
t(12) = 0.17, p = .87 for the last block).
Importantly, the above results were confirmed by studying the
ERNA during stimulation in the temporal domain (Fig. 3A). During
continuous DBS the evoked response can be observed between each pair
of consecutive stimulation artefacts, although it may also be present
during the stimulus artefact but obscured by the latter (see Fig. 4C). In
order to demonstrate the changing nature of the evoked activity over
time we selected the maximal discrete peak between the stimulus ar-
tefacts. This increased in latency and decreased in amplitude with sti-
mulation duration (Fig. 3B and Supplementary video V2) and is in line
with the change in frequency and amplitude observed in the spectral
domain (Fig. S2). Note that the latency of the selected peak may not
exactly correspond to the frequency of the ERNA measured in the
spectral domain, as in the latter case the analysis gives the dominant
frequency of the whole evoked response, and may include portions of
the evoked activity that overlap with the stimulation artefact (see
Fig. 4C). The time-domain analysis also confirmed the absence of an
ERNA during stimulation in the three patients mentioned previously
(patients 12–14, Table 2, Fig. S1).
3.2. ERNA after stimulation
As mentioned above, time domain analyses of the ERNA during
stimulation may be hindered by subsequent stimulation artefacts.
Accordingly, we also examined any activity that persisted after stimu-
lation was abruptly discontinued. As can be seen in Fig. 4A, a series of
high frequency waves followed cessation of stimulation and progres-
sively diminished in amplitude, similar to the ERNA previously de-
scribed in the literature (Sinclair et al., 2018). Across all hemispheres,
this resonant activity was composed of a series of 2 to 10 waves
C. Wiest, et al. Neurobiology of Disease 143 (2020) 105019
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(4.9 ± 0.4 on average, see Methods for criteria) lasting for 24 ± 2 ms
on average after the cessation of the stimulation. The initial frequency
of the ERNA, measured as the inverse of the delay between the first two
peaks, was similar to the steady state of the ERNA during stimulation
(initial frequency: 271.3 ± 11.7 Hz and ERNA steady state:
263.2 ± 2.1 Hz, paired t-test, t(10) = 0.82, p = .43). Note that two
STNs with an evoked potential during stimulation did not meet our
criteria for an ERNA response at offset of stimulation, although both
had an evoked response during stimulation (patients 2 and 7).
Moreover, this analysis confirmed the absence of an ERNA following
cessation of stimulation in patients 12 to 14 (Table 2, Fig. S1).
In order to study the modulation of the ERNA by preceding stimu-
lation we examined the data from 7 hemispheres (5 patients) in which a
second experimental condition was performed. In this paradigm DBS
was applied for a shorter period of time (14.1 ± 2 s). The comparison
of the resonant activity after short versus long DBS blocks revealed a
more marked ERNA after short stimulation blocks which lasted longer
(29.4 ± 2 ms vs 21.7 ± 1 ms, paired t-tests: t(6) = 3.3, p= .024) with
Fig. 2. ERNA during long stimulation blocks (condition 1)
characterised in the spectral domain. A. ERNA in Patient 5.
ERNA representation in a time-frequency plot (i) and power
spectral density (PSD) in serial 10-s windows (wind; n = 17)
(ii). Successive windows transition from black to light grey
and then to brown, showing the progression to steady state.
The arrow heads denote the frequency of the peak measured in
each window. The amplitude and frequency of this peak was
measured to give the results in (iii) and (iv). The change in the
ERNA frequency (iii) and amplitude (iv) over time are plotted
for the three blocks of stimulation separately. The time at
which steady state (SST) is reached corresponds to the first
point at which the derivate remains within a ± 5 Hz/s band
around zero and is indicated by dots for each block (see da-
shed grey line). B. Frequency characteristics of the ERNA at
the group level and across stimulation blocks. Black dots re-
present individual STNs. Linear mixed-effects models (LME)
reveal no significant modulation between blocks (see text).
Initial frequency and initial amplitude refer to the value of the
first 10-s bin. C. Amplitude characteristics of the ERNA at the
group level and across stimulation blocks. Linear mixed-effects
models reveal a significant modulation of the maximal am-
plitude (b =−0.06, t (38) =−3.56, p= .013) and the time to
reach the steady state (b = −6.27, t (38) = −2.21, p = .03)
over blocks. Bottom right; Averaged amplitude of the ERNA for
block 1 and block 4 (mean ± SEM). (For interpretation of the
references to colour in this figure legend, the reader is referred
to the web version of this article.)
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more waves observed (7.3 ± 0.6 vs 4.4 ± 0.2, paired t-test:
t(6) = 4.06, p = .007). In addition, the initial frequency and amplitude
of the ERNA were significantly higher after short stimulations
(t(6) = 5.2, p= .002 and t(6) = 2.48, p= .047, Fig. 4B). This change in
ERNA character following short and long duration stimulation periods
is in line with the shift to a lower steady state frequency during long
duration stimulation evident in the ERNA in the spectral domain
(Fig. 2A).
With the exception of patients 2 and 7, the ERNA following cessa-
tion of stimulation consisted of several waves lasting longer than the
inter-stimulus interval (ISI) during DBS at 130 Hz. This raises the
possibility that the steady state response during stimulation reflected
the temporal summation of overlapping evoked responses, where each
lasts longer than the ISI (see Fig. 4C).
3.3. Stimulation related dynamics in beta oscillations
The time–frequency plots showed a decrease in beta oscillatory
activity during continuous stimulation at 130 Hz, and a delayed return
of beta activity upon cessation of stimulation (labelled with “3” in
Fig. 1C). The suppression during and the delayed return of beta activity
are consistent with previous findings (Kühn et al., 2008; Eusebio et al.,
2011; Quinn et al., 2015; Whitmer et al., 2012), but the precise time-
course of beta suppression once stimulation has begun has not been
previously quantified. For each stimulation block, time-evolving power
changes were computed in the beta frequency band (13–34 Hz) in two
30-s windows aligned to the first or last stimulation artefact (Fig. 5A).
To allow the comparison with the previous ERNA analysis, only the
STNs showing an ERNA during stimulation were considered in the
following analysis (Table 2, patients 1 to 11, n = 13). However, due to
the contamination of the lower frequencies by involuntary movements
unequal numbers of STNs were analysed in consecutive stimulation
blocks (see Fig. 5A and Fig. 6C). The averaged time courses revealed a
rapid and sustained suppression of beta power during DBS followed by
a slower return to baseline level when DBS was switched off. The first
significant reduction of beta power (p < .05 after FDR correction) was
observed within the first 500 ms of stimulation (including a 200 ms
period in which stimulation amplitude was ramped up) in all the blocks,
whereas the baseline level was on average reached 8.9 ± 2.7 s after
cessation of stimulation.
To quantify the dynamics of the stimulation-induced changes in the
beta activity and compare them across consecutive blocks we averaged
the beta percentage change in shorter epochs of 10 s within the two
previously defined time windows (Fig. 5B). Linear mixed-effects mod-
elling indicated that the initial beta suppression was similar across the
four consecutive blocks (b = 1.9, t (30) = 1.1, p = .31). There was a
trend for beta suppression to reduce after long and repeated stimulation
but this did not reach significance (b = 2.9, t (28) = −2.1, p = .054).
During the washout epoch, the linear mixed-effects modelling was not
significant across blocks (b = −3.66, t (27) = −1.23, p = .23).
In the three STNs showing no ERNA, either during or after stimu-
lation blocks (see Table 2 and Fig. S1), the averaged beta power was
reduced during stimulation in two of them (subject 12: averaged beta
reduction of 20.1 ± 5.5% across the 3 blocks; subject 14:
26.7 ± 0.2%). In subject 13, there was no significant change in beta in
the three stimulation blocks (averaged beta increase of 5.6 ± 4.7%
across the 3 blocks).
Fig. 3. ERNA during long stimulation blocks (condition 1) in the temporal domain. A. Left; LFP traces at the start, when largest amplitude is reached, the middle
(after 60 s) and the end of the first long duration stimulation block of patient 5, revealing the presence of a changing evoked response between stimulation artefacts.
Right: Superimposition of 260 pulses (grey) and their average (blue). To demonstrate the changing nature of the evoked activity over time we selected the maximal
discrete peak between the stimulus artefacts in the first interval, tracked this peak throughout the stimulation block (indicated with a black arrowhead) and measured
the amplitude and latency of this evoked potential. B. Change in the averaged amplitude and latency of the selected peak over time at the group level
(mean ± SEM). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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3.4. Non-frequency selectivity of DBS induced power suppression
The frequency selectivity of DBS power suppression was tested by
quantifying the averaged power suppression across all blocks in three
other frequency bands; alpha/theta (4–12 Hz), low gamma (35–45 Hz)
and high gamma (70–90 Hz). Note that to avoid line noise, windows
were selected excluding the 50 and 100 Hz bands. In addition to the
beta power suppression (t(11) = 4.75, p < .001), there was a sig-
nificant decrease in low gamma power during stimulation (t(11) = 3.86,
p = .003, Fig. 6A). Based on these results we decided to explore the
temporal evolution of power changes in this frequency band with the
same procedure as for the beta band. When signals were aligned to the
start of the stimulation, we observed an abrupt reduction in low gamma
power, starting after 125 to 375 ms across the four stimulation blocks
and maintained throughout the entire stimulation (Fig. 6C). The aver-
aged initial power suppression was similar between the four stimulation
blocks (b = 2.8, t (30) = 1.1, p = .27), as was the averaged power
suppression in the last 10 s of stimulation (b = 0.8, t (28) = 0.73,
p = .47, Fig. 6B). Thus, when DBS was switched on the low gamma
power was rapidly suppressed, as previously observed for beta power.
The two frequency bands however showed different patterns when DBS
was switched off. As illustrated in Fig. 6D, after cessation of the sti-
mulation, low gamma power returned faster to its baseline level,
showing a slight overshoot (3.8 ± 0.9 s across all blocks and sides),
than beta power (8.9 ± 2.7 s, Wilcoxon signed-rank test; Z = 33,
p = .039).
3.5. Dynamics in high frequency oscillations (HFO)
The ERNA elicited by stimulation occurs in the same frequency
range as HFO (200–400 Hz). As suggested by the time frequency plot of
patient 5, the HFO activity seemed to decrease in frequency during DBS
(Fig. 1C, label 4). To test the modulation of this high frequency activity
we identified the HFO frequency peak in the absence of stimulation (to
avoid contamination by the ERNA, see methods) in five 20-s time
windows; one during the baseline, two immediately following long
duration blocks of DBS, and two at the end of the resting periods be-
tween such blocks (Fig. 7A). Note that only the first two DBS blocks
were considered to keep enough data points across all the tested STNs
(n = 13 STNs) as 2 patients performed only two long duration stimu-
lation blocks. A clear HFO peak was found in the baseline period in six
STNs (five patients), with a peak frequency of 242.5 ± 2.8 Hz, sig-
nificantly less than the initial (t(5) =−30.8, p < .001) or steady state
frequency of the ERNA (t(5) =−5.26, p = .033). The peak frequencies
of these HFO were significantly modulated across the five different time
windows (b = −5.1, t (26) = −2.82, p = .01 Fig. 7B). After the first
stimulation block, the HFO frequency was found to be significantly
decreased compared to baseline (OFF1: t(5) = 4.85, p = .005), before
increasing again and reaching a frequency close to baseline in the last
20 s of the resting period without stimulation (t(5) = 1.8, p= .13). This
pattern was also observed after the second stimulation block with an
initial reduction of the HFO frequency compared to the baseline
(t(5) = 4 0.89, p = .008) or the end of the previous rest period
(t(5) = 3.67, p = .02). Again, over the following rest period the HFO
peaks increased in frequency (t(5) = −5.6, p = .005) without, how-
ever, reaching the frequency observed during the baseline (t(5) = 3.44,
Fig. 4. ERNA after DBS. A. The ERNA is characterised by a series of high frequency waves following cessation of stimulation (time 0). These waves progressively
diminish in amplitude and frequency. Note that the first 1.5 ms (starting from the peak of the stimulation artefact) have been cut to avoid any contamination by the
stimulation artefact. The ERNA observed after the four long blocks of stimulation are superimposed. B. The ERNA is more marked after short than long stimulation
blocks. Grey dots; all individual ERNA for all blocks and STN. Black dots: averaged values for each STN. Grey dots are the results of individual stimulation blocks.
Paired t-tests, * p < .05, ** p < .01. C. ERNA after DBS superimposed on the ERNA observed during DBS.
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p = .026). Note that some authors describe two HFO peaks (Özkurt
et al., 2011), one centred around 250 Hz and another at higher fre-
quencies, with the latter peak preferentially occurring after treatment
with levodopa. We did not detect a peak at higher frequencies when not
stimulating, as our patients were recorded off medication.
3.6. Clinical correlations
As previously reported (Neumann et al., 2016), we confirmed the
correlation between normalised baseline beta power and the con-
tralateral UPDRS motor hemibody score OFF medication assessed pre-
operatively (r = 0.67, p = .024; see Fig. 8). In addition, there was a
trend towards a significant correlation between baseline beta power
and the UPDRS difference between OFF-ON medication (r = 0.58,
p = .06). In a further exploratory analysis we correlated the different
ERNA parameters with the pre-operative contralateral motor UPDRS
scores. This revealed a significant positive correlation between the time
taken for the ERNA amplitude to reach steady state and both the UPDRS
score OFF medication (r = 0.58, p = .037) and the difference between
UPDRS OFF and ON (r = 0.62, p = .024; see Fig. 8). For both the beta
power and the ERNA parameters, no significant correlation was ob-
served with the ipsilateral motor UPDRS scores.
4. Discussion
Here we analyse and contrast the evoked and induced changes in
STN activity in response to DBS of this target. The evoked response or
ERNA recorded during high frequency stimulation is known to initially
increase in amplitude at the start and then to decrease in both fre-
quency and amplitude over the course of a 60–90 s block of stimulation
(Sinclair et al., 2019b). Here we describe these dynamics in greater
detail, demonstrating that steady state frequency and amplitude are
reached after a minute or so of stimulation, and show a previously
unreported further diminution of maximal ERNA amplitude when long
duration blocks of stimulation are repeated. When stimulation ceases,
or more generally when stimulation frequency is low enough, the ERNA
is exposed as a series of waves of diminishing amplitude (Sinclair et al.,
2019b, 2018). Here we show that these waves last longer after cessation
Fig. 5. Modulation of beta power induced
by DBS. A. Averaged time course of % beta
power change relative to baseline (rest,
without stimulation) aligned to the first
(left) and last (right) stimulation artefact for
four consecutive stimulation blocks.
Mean ± SEM of %change from baseline
power is shown. Note that, because we
skipped data where movement occurred,
the number of STN (given by n) included
differs between windows. The periods
during which the beta power was sig-
nificantly different to zero are indicated by
the grey shading (one sample t-test,
p < .05 after FDR correction). B.
Comparison of averaged beta power
changes in the first and last 10s of DBS be-
tween the four consecutive blocks. Linear
mixed-effects models (LME) revealed a
trend for the last 10s of DBS to differ
(b = 2.9, t (28) = −2.1, p = .054).
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of short periods of stimulation than after longer periods of stimulation.
In contrast, DBS rapidly suppresses beta and low gamma band activity
in the STN LFP and steady state levels are thereafter relatively main-
tained during stimulation. In addition, the frequency of HFO in the STN
is below that of the ERNA, and is further reduced during DBS.
4.1. Origin of the ERNA
The ERNA consists of high amplitude and brief waves of local
activity time-locked to and evoked by stimulation pulses. One possibi-
lity raised by the evoked nature of the ERNA is that it is due to axonal
stimulation of inputs to the STN and is an analogue of the fibre volleys
measured in vitro, or compound action potentials measured in vivo, or,
related to this, it represents the post-synaptic response to synchronised
fibre volleys. Compound action potentials in the STN due to ortho-
dromic axonal stimulation of afferents have onset latencies of a milli-
second or so (Gmel et al., 2015), and would have been obscured by the
stimulation artefact and relatively low sampling rate in our study.
Fig. 6. DBS modulation of LFP in other frequency
bands. A. Averaged power changes in the four
frequency bands. One sample t-test, ** p < .01,
*** p < .001. B. Averaged low gamma power
changes in the first and last 10s of DBS. Both are
similar across the four stimulation blocks (linear
mixed-effects models, LME, b = 3.0, t (33) = 1.3,
p = .21 and b = 0.2, t (23) = 0.14, p = .89). C.
Averaged time course of low gamma power
aligned to the first (left) and last (right) stimula-
tion artefact for four consecutive stimulation
blocks. Note that, because we skipped data where
movement occurred, the number of STNs (given by
n) included differs between windows. The periods
during which the low gamma power was sig-
nificantly different to zero are indicated by grey
shading (one sample t-test, p < .05 after FDR
correction). D. Comparison of power recurrence
after cessation of DBS. Left: averaged group dy-
namics of spectral signals. Right: Power recurrence
to baseline across spectral components. Wilcoxon
signed rank test, * p < .05.
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However, longer latency compound action potentials may also be re-
corded in the STN and may reflect recurrent discharge due to anti-
dromic stimulation of the cerebral cortex through the hyperdirect
pathway (Gmel et al., 2015; Johnson et al., 2020; Miocinovic et al.,
2018; Walker et al., 2012), or possibly of recurrent discharge due to
stimulation of more local targets like the globus pallidus (Ramirez-
Zamora et al., 2020). In support of an origin of the ERNA related to
synchronised fibre volleys or the subsequent post-synaptic response to
them, both are reported to diminish in amplitude and increase in la-
tency during prolonged high frequency stimulation, due to the effects of
progressive axonal and synaptic failure (Rosenbaum et al., 2014;
Steiner et al., 2019). Short-term synaptic depression during high fre-
quency stimulation is mediated by decreased presynaptic calcium in-
flux, desensitisation and saturation of postsynaptic receptors and fewer
release-competent vesicles (Schneggenburger et al., 2002). While the
readily releasable vesicle pool and recycling pool in the presynapse are
exhausted within milliseconds to seconds, the reserve vesicle pool is
released during unphysiological high-frequency stimulation with
slower release kinetics and can last for tens of seconds to minutes. One
possibility therefore is that the initial increase in ERNA amplitude re-
lates to the short-lived increase in synaptic release or post-synaptic
potentiation during high frequency stimulation, and the progressive
relative exhaustion of the reserve vesicle pool thereafter accounts for
the drift to steady-state of the ERNA at lower amplitude and frequency
(Denker and Rizzoli, 2010; Rizzoli and Betz, 2005). This hypothesis is
supported by the observation that the progressive diminution of ERNA
frequency and amplitude is absent when stimulation is applied at only
20 Hz (Sinclair et al., 2019b), as diminution of the reserve vesicle pool
only occurs with high frequency stimulation (Rizzoli and Betz, 2005).
The above, however, does not explain the repetitive nature of the
ERNA unless it is assumed that the response to stimulation of the hy-
perdirect or indirect pathways is repetitive. Another possible me-
chanism for the ERNA is that it reflects an exaggeration of the network
responsible for spontaneously occurring HFO at rest (Sinclair et al.,
2019b). However, the HFO in our series had a lower initial frequency
than the ERNA, was driven to an even lower frequency, distinct from
that of the ERNA, during long duration stimulation and was only pre-
sent in less than half of cases demonstrating the ERNA. In contrast,
though, Sinclair et al. (2019b) reported that the median HFO peak
frequency immediately post-DBS shared the same frequency as the
ERNA during clinical stimulation.
4.2. Dynamics of the ERNA during and after DBS
A particular focus of the current study were the frequency and
amplitude dynamics of the ERNA. The cessation of stimulation reveals
that the ERNA consists of a series of oscillations at a similar frequency
to the steady state oscillation during stimulation, but of diminishing
amplitude. Such ‘ringing’ is suggestive of an underdamped resonance,
although it is possible that each wave is an independent evoked
Fig. 7. Modulation of HFO by DBS. A. Time frequency plots of the baseline and the 3 resting periods between long duration stimulation blocks in the HFO frequency
range for one patient. Power spectral densities were computed in 20 s windows as indicated by the dashed rectangles and either followed cessation of stimulation
(OFF: 20s) or preceded stimulation (−20s: ON). B. HFO peaks are significantly different between the baseline and the two first resting periods (b = −5.1, t
(26) = −2.82, p = .01). Following paired t-test with FDR correction, *, p < .05, ** p < .01.
Fig. 8. Clinical correlations. A. Correlation between normalised baseline beta
power and both the contralateral UPDRS Part III motor hemibody score OFF
and the difference between OFF and ON medication state. Spearman correla-
tion. Black dots; individual STN. B. Similar correlation with the time to reach
the ERNA steady state amplitude. Diff: difference between UPDRS OFF and ON
medication state.
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component. During continued stimulation, after a brief amplitude in-
crease, there is a progressive drop in both the ERNA frequency and
amplitude until a steady state is reached. Assuming resonance, the drop
in frequency and amplitude would be consistent with the increasing
damping of a driven oscillation that reaches and holds peak damping
during the steady state recording. These two damping processes seen
during and at the end of stimulation may be one-and-the-same. Thus, if
stimulation is ended early, before steady state amplitude and frequency
are reached, then the cessation of stimulation is followed by a ringing
with a higher initial amplitude and greater number of wave cycles,
consistent with reduced damping.
Two subjects did not show ringing upon termination of stimulation,
although, like others, they demonstrated an evoked activity during
stimulation. In these two cases we suggest that the damping process was
more marked leading to critical damping of the oscillations so that
these were not seen as repetitive on cessation of stimulation. More
importantly, with respect to some of the potential clinical applications
to be discussed later, these two cases raise the possibility that a mul-
tiphasic ERNA may not be consistently seen during chronic DBS.
Although a damped resonance might describe the neural network
behaviour it does not define the underlying mechanisms. We suggest
that damping might be due to the effects of relative axonal failure and
synaptic depression discussed above (Rosenbaum et al., 2014; Steiner
et al., 2019). Even so the nature of the resonance that is damped is
unclear. The correlation between the time for the ERNA to reach
steady-state and the severity of contralateral motor impairment off
medication might suggest that resonance is stronger when the Parkin-
sonian state is worse. The correlation between the time for the ERNA to
reach steady state and the degree of improvement possible with levo-
dopa might further suggest that resonance is exaggerated by dopami-
nergic under activity. A key question is whether the time taken to es-
tablish damping of the evoked response may be related to the time
taken for the development of clinical DBS effects. This would necessi-
tate frequent probing of motor function over the first minute or two
after stimulation onset; data that is not available in the literature.
4.3. Dynamics of background activities in response to DBS
Beta band oscillations in the STN LFP occur spontaneously, without
the need for extrinsic stimulation (Brown et al., 2001). Their amplitude
is one to two orders of magnitude less than that of the ERNA suggesting
that, although post-synaptic in origin, they represent either a far less
tightly synchronised activity in time, a sparser synchronisation in space,
or both. This synchronisation is coupled to cortical activity at the same
frequency, but lags this by about 20 ms, and is diminished by voluntary
movement (Oswal et al., 2013). Beta amplitude in the STN correlates
with pre-operative assessments of motor impairment (Neumann et al.,
2016), as confirmed here. Gamma band oscillations in the STN LFP are
also recorded at rest, but are of even smaller amplitude, tending to be
increased as a broad band activity during voluntary movement. This
increase during movement has led to speculation that they are
somehow involved in the coding of movement (Oswal et al., 2013).
The dynamics of the response to the continuous 130 Hz stimulation
of the STN differed between the ERNA and beta-low gamma activity.
The ERNA, or its damping, evolved slowly as stimulation was main-
tained or repeated, whereas beta and gamma oscillations responded
rapidly. These contrasting dynamics argue for differences in underlying
mechanisms, with the rapid suppression and recovery of the beta and
low gamma activity suggesting that this might be due to the more direct
desynchronising effects of high-frequency stimulation. These may re-
flect chaotic desynchronisation (Wilson et al., 2011), or the driving of
afferents to STN at high frequency, which supplants or over-rides pa-
thological inputs at lower frequency (Birdno and Grill, 2008;
Hashimoto et al., 2003; Moran et al., 2011). Both are physical phe-
nomena that may be able to establish themselves and desynchronise
population activity over relatively few stimulation cycles. The recovery
of beta activity following cessation of stimulation was, however,
slower, as previously reported (Bronte-Stewart et al., 2009; Kühn et al.,
2008), and might reflect the time taken for synchronisation to be re-
established at the network level. The time course of beta recovery was
similar to that reported for the acute return of bradykinesia and rigidity
(Bronte-Stewart et al., 2009; Kühn et al., 2009; Levin et al., 2009), but
there are additional slower recovery dynamics likely in rigidity, tremor,
axial impairment and postural instability (Koop et al., 2006; Shivitz
et al., 2006; Temperli et al., 2003; Vaillancourt et al., 2006). Whether
the decrement in maximal ERNA amplitude following repeated long
duration blocks of high frequency stimulation relates to some of these
slower symptom modulations seen with DBS requires further in-
vestigation.
4.4. Implications and applications of evoked and induced responses to DBS
The differing dynamics between the ERNA and beta activity have
implications with regard to their use as feedback signals in adaptive
DBS. Specifically, the rapid response of beta activity to the onset and
offset of stimulation means that it can be used to target beta bursts in
the STN (Little et al., 2013, 2016b, 2016a; Tinkhauser et al., 2017a;
Velisar et al., 2019). These are increasingly reported to play a key role
in the mechanism of bradykinesia and rigidity in PD (Deffains et al.,
2018; Tinkhauser et al., 2020, 2017a, 2017b; Torrecillos et al., 2018).
The ERNA does not provide direct feedback relevant to beta bursts and
undergoes relatively slow changes with respect to the duration of sti-
mulation. The ERNA could potentially better subserve more slowly
responsive control algorithms (Arlotti et al., 2018; Rosa et al., 2017).
Both the ERNA and beta activity may be of additional value in loca-
lising the dorsal ‘motor’ region of the STN during surgery (Sinclair
et al., 2018; Thevathasan et al., 2020; Zaidel et al., 2009), although it is
possible that the former may be particularly well suited to this as, in
one case it remained despite general anaesthesia (Sinclair et al., 2018).
In addition, both activities may facilitate prediction of the optimal
contact for stimulation following surgery (Chen et al., 2006b; Ince
et al., 2010; Sinclair et al., 2018; Thevathasan et al., 2020; Tinkhauser
et al., 2018; Yoshida et al., 2010).
The suppression of low gamma activity by DBS is interesting as this
activity is thought to help encode voluntary movements. Accordingly its
suppression by DBS may point to the non-specificity of this intervention
and help explain some of the motoric deterioration that may complicate
DBS. This is most clearly seen in isolated cranial dystonia patients,
when high frequency stimulation of the pallidum can cause paradoxical
motor deficits (Berman et al., 2009; Blahak et al., 2011; Huebl et al.,
2015; Wolf et al., 2016). However, stimulation of the STN may also
cause motor deficits. For example, this may be the case in verbal flu-
ency, which is impaired by DBS (Parsons et al., 2006), and has been
specifically linked to increased subthalamic gamma activity (Anzak
et al., 2011). It may also help explain the modest impairments in limb
motor function in PD patients who otherwise perform well when not
stimulated, i.e. those subjects who have relatively good background
motor performance at the time of testing (Chen et al., 2006a). The latter
may also contribute to the impairment of swimming ability during STN
DBS that has been recently highlighted (Waldvogel et al., 2020). Fi-
nally, the possibility should be acknowledged that the DBS induced
suppression of LFP activity spread to even higher frequency bands than
the low gamma range, but was masked by a coincidental rise in the
noise floor of the amplifier during stimulation.
These considerations are important as they argue that patients may
potentially never be able to achieve their optimal performance during
conventional continuous DBS, which might be relatively indiscriminate
in its effects on spontaneous oscillatory activity, and affect both pa-
thological and physiological oscillations. Such observations help moti-
vate the development of adaptive DBS approaches which partially spare
residual physiological processing in the subthalamic nucleus by redu-
cing the duration or intensity of stimulation (Arlotti et al., 2018; Little
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et al., 2013), or by delivering phase-dependent stimulation according to
neural feedback (Cagnan et al., 2017; Holt et al., 2019).
4.5. Limitations of the study
Our results may have been confounded by the post-operative stun
effect, which is known to lower beta activity (Chen et al., 2006b). In
addition, we did not simultaneously evaluate clinical state during our
recordings, which would be necessary to directly relate the dynamics of
ERNA characteristics and of beta suppression to the dynamics of the
clinical effects of DBS. This again would require a bigger cohort or the
opportunity to record in chronically implanted patients to avoid con-
founding DBS related LFP changes with movement-related effects im-
posed by clinical testing. Moreover, the symmetric biphasic pulse used
in the present study is not standard in clinical practice and our sampling
rate of 2048 Hz might have been too low to precisely describe and
follow the dynamics of the ERNA in the time domain. Finally, only 14
patients participated in our study and some of our contrasts involved
small subsets of patients (see Fig. 5A and Fig. 6C), so that these results
need to be confirmed in a larger series.
5. Conclusions
We have characterised the temporal dynamics of different responses
to DBS in the STN LFP, and speculated on the phenomena that may
underlie these changes. In particular, the relatively slow development
of damping evident in the ERNA after stimulation onset raises the
possibility of an underlying progressive axonal and synaptic failure.
Conversely, the very rapid onset of beta suppression following DBS
onset may reflect more direct desynchronising effects of high-frequency
stimulation. Notwithstanding the underlying mechanisms, the different
temporal dynamics exhibited by evoked and induced activities in re-
sponse to stimulation may impact on their use as feedback signals in
adaptive DBS.
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